StockGlow

Corline Biomedical AB (CLBIO.ST)

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.

17.50-0.01%Healthcare
Compare CLBIO.ST with
StockGlow Score
55
Neutral
BearishBullish
1 year ago+35.7%

The outlook

Corline Biomedical AB currently reads as neutral based on mixed vs its moving averages, 39% of the way from its 52-week low to high, avg target +66% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendMixed vs its moving averages
52-week range39% of the way from its 52-week low to high
Price targetAvg target +66% vs current price
Market cap
$457.3M
52-wk high
27.20
52-wk low
11.25
50-day avg
17.85
200-day avg
17.25
Trailing P/E
—

Similar stocks

CANTA.STCantargia AB (publ)$1.82+0.33%CLS-B.STClinical Laserthermia Systems AB (publ)$1.89-0.21%KLAR.STKlaria Pharma Holding AB (publ.)$0.86+5.26%GENO.STGenovis AB (publ.)$19.58-0.71%IMMU.STMendus AB (publ)$6.94+0.14%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy